Bristol Myers Squibb-Pfizer

Eliquis (apixaban) is an oral factor Xa inhibitor from Bristol-Myers Squibb and Pfizer. By interrupting one key step of the clotting cascade it prevents harmful clots, and is used to reduce stroke risk in atrial fibrillation and to treat and prevent deep vein thrombosis and pulmonary embolism.

When the body forms a clot, a series of proteins activate one another in a chain reaction. Apixaban directly blocks one of these proteins, factor Xa,